(Q35047634)

6 August 2017

title

The ABCs of RVO: a review of retinal venous occlusion (English)

1 reference

6 August 2017

Derek MacDonald

1

1 reference

6 August 2017

publication date

20 November 2013

1 reference

Clinical and Experimental Optometry

6 August 2017

published in

1 reference

6 August 2017

volume

97

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

311-323

1 reference

Retinal vein occlusion: pathophysiology and treatment options

6 August 2017

cites work

1 reference

Clinical practice. Retinal-vein occlusion

21 January 2018

1 reference

Central retinal vein occlusion: a review

21 January 2018

1 reference

Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities

21 January 2018

1 reference

Retinal vein occlusion: beyond the acute event

21 January 2018

1 reference

Central retinal vein occlusion: what's the story?

21 January 2018

1 reference

Retinal vein thrombosis: pathogenesis and management

21 January 2018

1 reference

Best practices for treatment of retinal vein occlusion.

21 January 2018

1 reference

Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature

21 January 2018

1 reference

Ophthalmodynamometric assessment of the central retinal vein collapse pressure in eyes with retinal vein stasis or occlusion

21 January 2018

1 reference

Association of inflammatory factors with macular edema in branch retinal vein occlusion.

21 January 2018

1 reference

Vascular endothelial growth factor a in intraocular vascular disease

21 January 2018

1 reference

Fluorescein angiography and its prognostic significance in central retinal vein occlusion

21 January 2018

1 reference

Visual function and serous retinal detachment in patients with branch retinal vein occlusion and macular edema: a case series

21 January 2018

1 reference

Natural history of visual outcome in central retinal vein occlusion

21 January 2018

1 reference

Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion

21 January 2018

1 reference

The 10-year incidence and risk factors of retinal vein occlusion: the Beijing eye study

21 January 2018

1 reference

Vascular crossing patterns in patients with systemic arterial hypertension

21 January 2018

1 reference

Fundus changes in central retinal artery occlusion.

21 January 2018

1 reference

Progressive optic nerve collateralization after serial intravitreal ranibizumab injections for central retinal vein occlusion.

21 January 2018

1 reference

Emerging roles for antiangiogenesis factors in management of ocular disease.

21 January 2018

1 reference

The management of retinal vein occlusion: is interventional ophthalmology the way forward?

21 January 2018

1 reference

Evaluation of potential visual acuity in eyes with macular oedema secondary to retinal vein occlusion.

21 January 2018

1 reference

Spectral-domain optical coherence tomography (SD-OCT) patterns and response to intravitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusion

21 January 2018

1 reference

Association between integrity of foveal photoreceptor layer and visual acuity in branch retinal vein occlusion

21 January 2018

1 reference

Fundus autofluorescence and optical coherence tomography findings in branch retinal vein occlusion

21 January 2018

1 reference

Clinical course of younger patients with central retinal vein occlusion

21 January 2018

1 reference

Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.

21 January 2018

1 reference

Surgical induction of chorioretinal venous anastomosis in ischaemic central retinal vein occlusion: a non-randomised controlled clinical trial

21 January 2018

1 reference

Long-term effect of early intervention with single intravitreal injection of bevacizumab followed by panretinal and macular grid photocoagulation in central retinal vein occlusion (CRVO) with macular edema: a pilot study

21 January 2018

1 reference

Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study

21 January 2018

1 reference

Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial

21 January 2018

1 reference

The expanding role of vascular endothelial growth factor inhibitors in ophthalmology

21 January 2018

1 reference

Central retinal vein occlusion: a case report and review of the literature

21 January 2018

1 reference

Retinal vein occlusion: current treatment

21 January 2018

1 reference

Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study.

21 January 2018

1 reference

A longitudinal analysis of risk factors associated with central retinal vein occlusion

21 January 2018

1 reference

Activated protein C resistance in young adults with central retinal vein occlusion

21 January 2018

1 reference

Central retinal vein occlusion case-control study

21 January 2018

1 reference

Prevalence of factor V Leiden and activated protein C resistance in central retinal vein occlusion

21 January 2018

1 reference

Sleep apnea and risk of retinal vein occlusion: a nationwide population-based study of Taiwanese.

21 January 2018

1 reference

Association of MMP2-1306C/T and TIMP2G-418C polymorphisms in retinal vein occlusion.

21 January 2018

1 reference

Aqueous vascular endothelial growth factor and endothelin-1 levels in branch retinal vein occlusion associated with normal tension glaucoma

21 January 2018

1 reference

Practical management of retinal vein occlusions

21 January 2018

1 reference

10-Year Framingham risk in patients with retinal vein occlusion: a systematic review and meta-analysis

21 January 2018

1 reference

A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution

21 January 2018

1 reference

Central and hemicentral retinal vein occlusion: role of anti-platelet aggregation agents and anticoagulants

21 January 2018

1 reference

Ocular blood flow levels and visual prognosis in a patient with nonischemic type central retinal vein occlusion

21 January 2018

1 reference

The rationale of retinal endovascular fibrinolysis in the treatment of retinal vein occlusion: from experimental data to clinical application

21 January 2018

1 reference

Retinal endovascular surgery for central retinal vein occlusion: initial experience of four surgeons

21 January 2018

1 reference

The Central Retinal Vein Bypass Study: a trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion

21 January 2018

1 reference

Laser-induced chorioretinal venous anastomosis for nonischemic central or branch retinal vein occlusion

21 January 2018

1 reference

Factors promoting success and influencing complications in laser-induced central vein bypass

21 January 2018

1 reference

Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: a prospective review of 15 cases

21 January 2018

1 reference

Vitrectomy with complete posterior hyaloid removal for ischemic central retinal vein occlusion: series of cases

21 January 2018

1 reference

Interventions for central retinal vein occlusion: an evidence-based systematic review

21 January 2018

1 reference

Vitreous attachment in age-related macular degeneration, diabetic macular edema, and retinal vein occlusion: a systematic review and metaanalysis

21 January 2018

1 reference

Relation of intraocular concentrations of inflammatory factors and improvement of macular edema after vitrectomy in branch retinal vein occlusion.

21 January 2018

1 reference

Pentraxin 3 and other inflammatory factors in central retinal vein occlusion and macular edema

21 January 2018

1 reference

Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases

21 January 2018

1 reference

Radial optic neurotomy as treatment for central retinal vein occlusion

21 January 2018

1 reference

Fundus and histopathological study of radial optic neurotomy in the normal miniature pig eye.

21 January 2018

1 reference

Chorioretinal Anastomosis After Radial Optic Neurotomy for Central Retinal Vein Occlusion

21 January 2018

1 reference

Peripapillary haemorrhagic retinal pigment epithelium detachment following radial optic neurotomy

21 January 2018

1 reference

Interventions for branch retinal vein occlusion: an evidence-based systematic review

21 January 2018

1 reference

Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion

21 January 2018

1 reference

Xenon arc panretinal photocoagulation for central retinal vein occlusion: a randomised prospective study

21 January 2018

1 reference

Panretinal photocoagulation in central retinal vein occlusion: A randomised controlled clinical study

21 January 2018

1 reference

Vascular endothelial growth factor: basic science and clinical progress

21 January 2018

1 reference

Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial

21 January 2018

1 reference

Actions of bevacizumab and ranibizumab on microvascular retinal endothelial cells: similarities and differences

21 January 2018

1 reference

Pegaptanib sodium for macular edema secondary to central retinal vein occlusion

21 January 2018

1 reference

Long-term evaluation of patients treated with dexamethasone intravitreal implant for macular edema due to retinal vein occlusion

21 January 2018

1 reference

Use of intravitreal triamcinolone in the treatment of macular edema related to retinal vein occlusion

21 January 2018

1 reference

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal [...]

21 January 2018

1 reference

Baseline characteristics and response to treatment of participants with hemiretinal compared with branch retinal or central retinal vein occlusion in the standard care vs corticosteroid for retinal vein occlusion (SCORE) study: SCORE study report 14

21 January 2018

1 reference

SCOREing in retinal venous occlusive disease

21 January 2018

1 reference

Macular sensitivity and morphology after intravitreal injection of triamcinolone acetonide for macular edema secondary to central retinal vein occlusion

21 January 2018

1 reference

Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.

21 January 2018

1 reference

Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results

21 January 2018

1 reference

Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (Shasta study).

21 January 2018

1 reference

Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant

21 January 2018

1 reference

Vascular changes in eyes treated with dexamethasone intravitreal implant for macular edema after retinal vein occlusion.

21 January 2018

1 reference

Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial.

21 January 2018

1 reference

Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease

21 January 2018

1 reference

Aflibercept for age-related macular degeneration: a game-changer or quiet addition?

21 January 2018

1 reference

Targeted deletion of Vegfa in adult mice induces vision loss

21 January 2018

1 reference

Broad spectrum antiangiogenic treatment for ocular neovascular diseases

21 January 2018

1 reference

Intravitreal bevacizumab for retinal vein occlusion and early growth of epiretinal membrane: a possible secondary effect?

21 January 2018

1 reference

Avastin doesn't blind people, people blind people

21 January 2018

1 reference

Economic considerations of macular edema therapies

21 January 2018

1 reference

Intravitreous bevacizumab adult safety data: the evidence so far.

21 January 2018

1 reference

Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study.

21 January 2018

1 reference

Treatment of branch retinal vein occlusion induced macular edema with bevacizumab

21 January 2018

1 reference

The treatment of branch retinal vein occlusion with bevacizumab

21 January 2018

1 reference

Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab

21 January 2018

1 reference

Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months

21 January 2018

1 reference

Bevacizumab (Avastin) for the treatment of neovascular glaucoma.

21 January 2018

1 reference

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion

21 January 2018

1 reference

Predictive value in retinal vein occlusions of early versus late or incomplete ranibizumab response defined by optical coherence tomography

21 January 2018

1 reference

Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study

21 January 2018

1 reference

Insight into 144 patients with ocular vascular events during VEGF antagonist injections

21 January 2018

1 reference

A lack of delayed intraocular pressure elevation in patients treated with intravitreal injection of bevacizumab and ranibizumab.

21 January 2018

1 reference

Effect on intraocular pressure in patients receiving unilateral intravitreal anti-vascular endothelial growth factor injections

21 January 2018

1 reference

Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents

21 January 2018

1 reference

The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema

21 January 2018

1 reference

Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS study.

21 January 2018

1 reference

VEGF Trap-Eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the phase III GALILEO study.

21 January 2018

1 reference

Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study

21 January 2018

1 reference

Aflibercept for central retinal vein occlusion: an ongoing revolution or are we spinning in place?

21 January 2018

1 reference

Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion

21 January 2018

1 reference

Twelve-month experience with Ozurdex for the treatment of macular edema associated with retinal vein occlusion

21 January 2018

1 reference

Does laser still have a role in the management of retinal vascular and neovascular diseases?

21 January 2018

1 reference

Prospective study of peripheral panretinal photocoagulation of areas of nonperfusion in central retinal vein occlusion

21 January 2018

1 reference

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results

21 January 2018

1 reference

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

21 January 2018

1 reference

Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial

21 January 2018

1 reference

Comparing bevacizumab and ranibizumab for initial reduction of central macular thickness in patients with retinal vein occlusions

21 January 2018

1 reference

Systemic effects of intravitreal vascular endothelial growth factor inhibitors

21 January 2018

1 reference

Myocardial infarction after intravitreal vascular endothelial growth factor inhibitors: a whole population study

21 January 2018

1 reference

The potential of nanomedicine therapies to treat neovascular disease in the retina.

21 January 2018

1 reference

LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling.

21 January 2018

1 reference

Neuroprotective effect of minocycline in a rat model of branch retinal vein occlusion

21 January 2018

1 reference

Hemodilution therapy using automated erythrocytapheresis in central retinal vein occlusion: results of a multicenter randomized controlled study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CXO.12120

1 reference

6 August 2017

1 reference